Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 4/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | MPO | P05164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16105820 | 0.80 | DAO (0.55) | HTTALDH1A1CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL3299911 | 0.80 | CYP17A1 (0.52) | HTTALDH1A1CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL3246622 | 0.79 | DAO (0.46) | HTTALDH1A1CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL28041389 | 0.78 | HTT (0.47) | HTTALDH1A1CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL6890833 | 0.77 | CYP17A1 (0.46) | ALDH1A1CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL12533678 | 0.77 | KDM1A (0.38) | HTTALDH1A1KDM1A | |
| SCHEMBL15827407 | 0.77 | CA6 (0.52) | ALDH1A1 | |
| SCHEMBL11244115 | 0.77 | KDM4E (0.49) | ALDH1A1MAOAMAOBKDM1A | |
| SCHEMBL6890826 | 0.77 | RIPK1 (0.31) | HTTALDH1A1DAORIPK1 | |
| SCHEMBL16388285 | 0.77 | PIK3CA (0.45) | HTTALDH1A1DAOMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110611086-B | Negative active material for rechargeable lithium battery and rechargeable lithium battery including the same | 三星SDI株式会社 | 2022-06-14 | — | — | CN | disclosed |
| CN-109802102-B | Positive active material for rechargeable lithium battery, rechargeable lithium battery including the same, and battery module including the same | 三星SDI株式会社 | 2022-03-15 | — | — | CN | disclosed |
| CN-111146413-A | Positive active material for rechargeable lithium battery, method of preparing the same, and rechargeable lithium battery including the same | 三星SDI株式会社 | 2020-05-12 | — | — | CN | disclosed |
| CN-110611086-A | Negative active material for rechargeable lithium battery and rechargeable lithium battery including the same | 三星SDI株式会社 | 2019-12-24 | — | — | CN | disclosed |
| EP-1506175-A1 | N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003097609-A1 | N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-11-27 | — | — | WO | disclosed |